Skip to content

Clinical Validation of Omron WheezeScan

Clinical Validation of Omron WheezeScan

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04144699
Enrollment
240
Registered
2019-10-30
Start date
2019-11-01
Completion date
2021-12-31
Last updated
2021-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma in Children, Bronchiolitis, Bronchitis

Keywords

wheeze, rhonchus

Brief summary

The WheezeScan sensitivity and specificity are set to statistically prove equal to or higher values than the predicate PulmoTrack device model 2020.

Interventions

None listed

Sponsors

University of Wisconsin, Madison
CollaboratorOTHER
Children's Hospital Medical Center, Cincinnati
CollaboratorOTHER
University of Chicago
CollaboratorOTHER
Omron Healthcare Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Months to 8 Years
Healthy volunteers
No

Inclusion criteria

Mild to moderate diagnosed or suspected asthma, bronchitis, or bronchiolitis patients who meet all of the following criteria are considered as eligible. 1. Does the subject have mild to moderate diagnosed or suspected asthma, bronchitis, or bronchiolitis? 2. Is the subject between the ages of 3 months to 8 years old? 3. Is the parent or legal guardian available, and capable and willing to give a consent on the child's behalf.

Exclusion criteria

The subjects will be excluded from the study, if they have any of the following criteria. 1. Does the subject have skin rashes or wounds on the chest? 2. Does the subject have known allergies or irritant contact dermatitis or having hypersensitive skin? 3. Does the subject have a defibrillator and/or pacemaker (which could interfere with the sounds to be detected)? 4. Does the subject have an allergy to disinfecting alcohol? 5. Does the subject have wheezes caused by not asthma, such as reflux esophagitis, pneumonia, vocal cord dysfunction, Tracheomatosis? 6. Does the subject have a heavy runny nose? 7. Is it difficult to hear auscultation due to the subject fussing, crying or vocalizing at data collection? 8. Is the subject having difficulty breathing or having severe symptoms? 9. Was the subject enrolled more than once for the same resulted breath sounds? * Note: The subject maybe enrolled once per arm (once wheezing, once non-wheezing).

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the sensitivity and specificity of the Omron WheezeScan deviceNovemver 1, 2019 ~ November 30, 2021The WheezeScan device will be compared to the gold standard, auscultation, which will be performed by a physician or a qualified healthcare professional with a minimum of 3 years' experience. All breath sounds will be recorded for comparison in case of discrepancy.

Countries

United States

Contacts

Primary ContactNaoto Ohgami
naoto.ogami@omron.com+81-75-925-2304
Backup ContactKatie May
katie.may@omron.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026